0 hr Pre-dose concentration but less than 5% of Cmax [Regulatives / Guidelines]

posted by jag009  – NJ, 2012-03-29 19:34  – Posting: # 8349
Views: 6,939

Hi everyone,

Regarding the FDA guidance on pre-dose concentration:

"If the predose concentration is less than or equal to 5 percent of Cmax value in that subject, the subjects data without any adjustments can be included in all pharmacokinetic measurements and calculations. If the predose value is greater than 5 percent of Cmax, the subject should be dropped from all BE study evaluations."

What if a subject has a pre-dose concentration in period 1? Should the subject still be kept or needs to be removed since he shouldn't have any pre-dose concentration in period 1.

Clinic shows no deviations and data was reviewed.



Complete thread:

 Admin contact
20,113 posts in 4,245 threads, 1,383 registered users;
online 11 (2 registered, 9 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 17:17 CET

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz